NEW YORK (GenomeWeb News) – Rosetta Genomics today said in its earnings report for the fourth quarter of 2007 that it is “solidly on target” to launch three diagnostic microRNA tests in the coming year, but as it currently has no products on the market it posted no revenues for 2007.
 
In addition, the company’s net loss nearly tripled as it spent more on increased R&D and selling and general expenses rose.  
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.